[["index.html", "SCOPE &amp; STOP Hormones and MetS Analysis Overview", " SCOPE &amp; STOP Hormones and MetS Analysis 20 December 2023 Overview This page contains analysis results for SCOPE and STOP Hormones and metabolic syndrome analysis. Part I: MetS This section contains analyses of hormones vs metabolic syndrome (new criteria). "],["part-mets.html", "(PART*) MetS", " (PART*) MetS "],["descriptives.html", "1 Descriptives", " 1 Descriptives Descriptives with univariate P-values. Characteristic No MetS (n=2032) MetS (n=312) Total (n=2344) P-value PRL (ng/ml): Median (IQ range) 96.4 (57.9-158.7) 107.5 (57.0-180.3) 97.6 (57.8-161.6) 0.11 hPL (μg/ml): Median (IQ range) 102.1 (54.1-176.6) 124.7 (51.4-172.9) 105.2 (54.0-176.0) 0.70 GH2 (ng/ml): Median (IQ range) 2.4 (1.2-4.1) 2.7 (1.5-4.3) 2.5 (1.2-4.2) 0.11 Insulin (uU/ml): Median (IQ range) 10.5 (6.1-21.4) 30.7 (15.1-53.4) 11.7 (6.5-24.6) &lt;0.0001 HOMA-IR: Median (IQ range) 2.3 (1.3-4.8) 7.6 (3.4-14.4) 2.6 (1.4-5.7) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.4) 5.8 (5.3-6.2) 5.0 (4.6-5.6) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 39.2 (33.4-44.2) 37.6 (31.1-43.4) 39.0 (33.2-44.1) 0.01 B12 concentration (pM): Median (IQ range) 266.0 (208.0-341.5) 243.0 (193.0-301.0) 262.0 (205.8-337.0) &lt;0.0001 Folate:B12 ratio: Mean (SD) 197.2 (204.0) 192.2 (148.5) 196.6 (197.7) 0.61 Active B12 concentration (pM): Mean (SD) 64.5 (24.9) 66.1 (26.1) 64.7 (25.1) 0.46 Folate:Active B12 ratio: Mean (SD) 825.3 (733.8) 741.3 (702.3) 813.3 (729.7) 0.15 Homocysteine concentration (μM): Mean (SD) 4.8 (1.2) 4.6 (1.1) 4.8 (1.2) 0.004 CRP (mg/L): Median (IQ range) 3.7 (1.7-7.2) 6.9 (3.5-11.3) 4.1 (1.9-7.7) &lt;0.0001 Folic acid supplement (μg): N(%) 0.03 Missing 126 (6.2) 13 (4.2) 139 (5.9) None 272 (13.4) 51 (16.3) 323 (13.8) &lt;=400 106 (5.2) 23 (7.4) 129 (5.5) &gt;400 to &lt;800 615 (30.3) 109 (34.9) 724 (30.9) &gt;=800 913 (44.9) 116 (37.2) 1029 (43.9) "],["within-scope.html", "1.1 Within SCOPE", " 1.1 Within SCOPE Characteristic No MetS (n=946) MetS (n=200) Total (n=1146) P-value PRL (ng/ml): Median (IQ range) 138.1 (90.7-223.7) 143.7 (92.4-213.9) 139.7 (91.4-222.3) 0.74 hPL (μg/ml): Median (IQ range) 181.3 (149.4-217.7) 167.1 (133.1-201.8) 179.7 (147.1-215.6) 0.002 GH2 (ng/ml): Median (IQ range) 4.2 (3.2-5.8) 3.7 (2.7-5.4) 4.2 (3.1-5.7) 0.02 Insulin (uU/ml): Median (IQ range) 12.3 (6.2-25.8) 34.7 (17.9-59.5) 14.5 (6.8-31.8) &lt;0.0001 HOMA-IR: Median (IQ range) 2.9 (1.4-6.2) 9.3 (4.4-16.5) 3.4 (1.6-7.8) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.3 (4.9-5.7) 5.9 (5.6-6.4) 5.4 (5.0-5.8) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 36.1 (28.3-42.8) 36.3 (28.8-43.0) 36.1 (28.4-42.8) 0.97 B12 concentration (pM): Median (IQ range) 249.0 (196.0-316.0) 233.0 (191.5-292.5) 245.0 (195.0-310.0) 0.008 Folate:B12 ratio: Median (IQ range) 142.5 (101.5-205.9) 152.3 (115.2-212.8) 144.1 (103.5-209.0) 0.17 Active B12 concentration (pM): Median (IQ range) 56.0 (42.0-73.0) 59.0 (45.0-77.0) 57.0 (43.0-74.0) 0.21 Folate:Active B12 ratio: Median (IQ range) 617.0 (450.9-913.3) 556.9 (405.0-783.0) 608.2 (438.8-900.5) 0.06 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.3 (3.7-4.9) 4.4 (3.8-5.0) 0.02 CRP (mg/L): Median (IQ range) 4.5 (2.4-8.3) 7.2 (4.1-11.2) 5.0 (2.5-9.1) &lt;0.0001 Folic acid supplement (μg): N(%) 0.30 Missing 0 (0.0) 0 (0.0) 0 (0.0) None 199 (21.0) 44 (22.0) 243 (21.2) &lt;=400 95 (10.0) 21 (10.5) 116 (10.1) &gt;400 to &lt;800 414 (43.8) 74 (37.0) 488 (42.6) &gt;=800 238 (25.2) 61 (30.5) 299 (26.1) "],["within-stop.html", "1.2 Within STOP", " 1.2 Within STOP Characteristic No MetS (n=1086) MetS (n=112) Total (n=1198) P-value PRL (ng/ml): Median (IQ range) 74.0 (48.5-114.8) 69.6 (44.4-113.1) 73.7 (48.3-114.4) 0.47 hPL (μg/ml): Median (IQ range) 60.2 (40.8-90.2) 50.0 (34.0-69.9) 59.2 (39.7-89.0) 0.0006 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.3) 1.3 (0.9-2.2) 1.4 (0.9-2.3) 0.47 Insulin (uU/ml): Median (IQ range) 9.6 (5.9-18.3) 24.2 (13.4-46.9) 10.5 (6.3-20.7) &lt;0.0001 HOMA-IR: Median (IQ range) 2.0 (1.2-3.9) 5.9 (3.0-11.6) 2.2 (1.3-4.4) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.0) 5.3 (4.8-5.8) 4.7 (4.4-5.1) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 40.6 (36.3-46.8) 39.4 (34.6-44.5) 40.4 (36.2-45.3) 0.03 B12 concentration (pM): Median (IQ range) 281.0 (220.0-363.0) 261.0 (200.5-330.5) 278.0 (218.0-357.0) 0.009 Folate:B12 ratio: Median (IQ range) 151.8 (114.8-222.1) 156.3 (118.6-217.0) 152.2 (114.8-221.9) 0.59 Active B12 concentration (pM): Median (IQ range) 65.0 (49.8-86.0) 66.0 (54.5-88.0) 66.0 (50.0-86.5) 0.67 Folate:Active B12 ratio: Median (IQ range) 630.6 (461.4-920.8) 561.5 (448.6-738.4) 626.0 (461.0-885.0) 0.09 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.8 (4.2-5.5) 4.8 (4.2-5.6) 0.75 CRP (mg/L): Median (IQ range) 3.2 (1.3-6.1) 6.2 (3.2-11.6) 3.4 (1.4-6.6) &lt;0.0001 Folic acid supplement (μg): N(%) 0.008 Missing 126 (11.6) 13 (11.6) 139 (11.6) None 73 (6.7) 7 (6.2) 80 (6.7) &lt;=400 11 (1.0) 2 (1.8) 13 (1.1) &gt;400 to &lt;800 201 (18.5) 35 (31.2) 236 (19.7) &gt;=800 675 (62.2) 55 (49.1) 730 (60.9) Red cell folate (nmol/L): Median (IQ range) 1476.5 (1216.0-1775.5) 1517.0 (1278.2-1792.0) 1483.0 (1220.5-1782.8) 0.22 "],["models.html", "2 Models", " 2 Models Fit GEE models to account for repeated measures. Outcomes: Hormones, Insulin, Glucose (all outcomes log-transformed) Independent variables: Study, GA at sampling Model fitted: LME model       log(hormones) ~ Study + GA at sampling + Study:GA at sampling&quot;)       Unstructured covariance matrix The following outcomes do not have repeated measures and analysed using multiple linear regression: Folate Folate:B12 CRP RCF BMI FA supplementation "],["prl-ngml.html", "2.1 PRL (ng/ml)", " 2.1 PRL (ng/ml) GEE for repeated measures. Model summary Var Effect P (Intercept) 15.78 (10.30, 24.17) &lt;0.0001 metab.C2MetS 0.97 (0.85, 1.12) 0.69 StudySTOP 0.93 (0.82, 1.06) 0.29 GA_samp 1.15 (1.12, 1.18) &lt;0.0001 metab.C2MetS:StudySTOP 0.99 (0.80, 1.22) 0.91 Estimated marginal means metab.C2 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 101.90 4.30 Inf 93.81 110.68 MetS SCOPE 99.08 7.54 Inf 85.35 115.01 No MetS STOP 94.89 3.33 Inf 88.58 101.65 MetS STOP 91.06 7.50 Inf 77.48 107.02 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.97 (0.85, 1.12) 0.7 MetS / No MetS Study: STOP 0.96 (0.81, 1.13) 0.6 STOP / SCOPE MetS (new): No MetS 0.93 (0.82, 1.06) 0.3 STOP / SCOPE MetS (new): MetS 0.92 (0.73, 1.16) 0.5 "],["hpl-μgml.html", "2.2 hPL (μg/ml)", " 2.2 hPL (μg/ml) GEE for repeated measures. Model summary Var Effect P (Intercept) 2.06 (1.69, 2.53) &lt;0.0001 metab.C2MetS 0.90 (0.85, 0.96) 0.0009 StudySTOP 1.08 (1.02, 1.14) 0.005 GA_samp 1.33 (1.32, 1.35) &lt;0.0001 metab.C2MetS:StudySTOP 0.91 (0.82, 1.01) 0.09 Estimated marginal means metab.C2 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 92.12 1.73 Inf 88.80 95.57 MetS SCOPE 83.34 2.63 Inf 78.34 88.66 No MetS STOP 99.50 1.39 Inf 96.82 102.27 MetS STOP 82.19 3.56 Inf 75.50 89.47 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.90 (0.85, 0.96) 0.0009 MetS / No MetS Study: STOP 0.83 (0.76, 0.90) &lt;0.0001 STOP / SCOPE MetS (new): No MetS 1.08 (1.02, 1.14) 0.005 STOP / SCOPE MetS (new): MetS 0.99 (0.88, 1.10) 0.8 "],["gh2-ngml.html", "2.3 GH2 (ng/ml)", " 2.3 GH2 (ng/ml) GEE for repeated measures. Model summary Var Effect P (Intercept) 0.07 (0.06, 0.10) &lt;0.0001 metab.C2MetS 0.87 (0.80, 0.95) 0.001 StudySTOP 0.99 (0.91, 1.07) 0.75 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 metab.C2MetS:StudySTOP 1.11 (0.96, 1.28) 0.14 Estimated marginal means metab.C2 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 2.38 0.06 Inf 2.26 2.50 MetS SCOPE 2.07 0.09 Inf 1.90 2.26 No MetS STOP 2.34 0.05 Inf 2.24 2.45 MetS STOP 2.27 0.13 Inf 2.03 2.53 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.87 (0.80, 0.95) 0.001 MetS / No MetS Study: STOP 0.97 (0.87, 1.08) 0.6 STOP / SCOPE MetS (new): No MetS 0.99 (0.91, 1.07) 0.7 STOP / SCOPE MetS (new): MetS 1.09 (0.94, 1.27) 0.2 "],["insulin-uuml.html", "2.4 Insulin (uU/ml)", " 2.4 Insulin (uU/ml) GEE for repeated measures. Model summary Var Effect P (Intercept) 10.09 (6.34, 16.06) &lt;0.0001 metab.C2MetS 2.50 (2.15, 2.91) &lt;0.0001 StudySTOP 0.88 (0.75, 1.02) 0.09 GA_samp 1.02 (0.99, 1.05) 0.26 metab.C2MetS:StudySTOP 0.94 (0.74, 1.19) 0.58 Estimated marginal means metab.C2 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 12.61 0.64 Inf 11.41 13.94 MetS SCOPE 31.52 2.36 Inf 27.21 36.51 No MetS STOP 11.05 0.42 Inf 10.26 11.90 MetS STOP 25.83 2.42 Inf 21.49 31.04 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 2.50 (2.15, 2.91) &lt;0.0001 MetS / No MetS Study: STOP 2.34 (1.95, 2.81) &lt;0.0001 STOP / SCOPE MetS (new): No MetS 0.88 (0.75, 1.02) 0.09 STOP / SCOPE MetS (new): MetS 0.82 (0.64, 1.05) 0.1 "],["homa-ir.html", "2.5 HOMA-IR", " 2.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 2.44 (1.50, 3.96) 0.0003 metab.C2MetS 2.82 (2.39, 3.33) &lt;0.0001 StudySTOP 0.77 (0.66, 0.90) 0.001 GA_samp 1.02 (0.98, 1.05) 0.33 metab.C2MetS:StudySTOP 0.95 (0.73, 1.23) 0.70 Estimated marginal means metab.C2 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 2.99 0.16 Inf 2.69 3.32 MetS SCOPE 8.44 0.69 Inf 7.19 9.90 No MetS STOP 2.30 0.09 Inf 2.12 2.48 MetS STOP 6.16 0.63 Inf 5.04 7.52 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 2.82 (2.39, 3.33) &lt;0.0001 MetS / No MetS Study: STOP 2.68 (2.20, 3.27) &lt;0.0001 STOP / SCOPE MetS (new): No MetS 0.77 (0.66, 0.90) 0.001 STOP / SCOPE MetS (new): MetS 0.73 (0.56, 0.96) 0.02 "],["glucose-mmoll.html", "2.6 Glucose (mmol/L)", " 2.6 Glucose (mmol/L) GEE for repeated measures. Model summary Var Effect P (Intercept) 5.40 (4.94, 5.90) &lt;0.0001 metab.C2MetS 1.15 (1.09, 1.21) &lt;0.0001 StudySTOP 0.88 (0.85, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.79 metab.C2MetS:StudySTOP 0.99 (0.93, 1.06) 0.84 Estimated marginal means metab.C2 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 5.34 0.05 Inf 5.24 5.44 MetS SCOPE 6.13 0.16 Inf 5.83 6.45 No MetS STOP 4.69 0.03 Inf 4.62 4.76 MetS STOP 5.35 0.09 Inf 5.18 5.53 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 1.15 (1.09, 1.21) &lt;0.0001 MetS / No MetS Study: STOP 1.14 (1.10, 1.18) &lt;0.0001 STOP / SCOPE MetS (new): No MetS 0.88 (0.85, 0.90) &lt;0.0001 STOP / SCOPE MetS (new): MetS 0.87 (0.82, 0.92) &lt;0.0001 "],["serum-folate-concentration-nm.html", "2.7 Serum folate concentration (nM)", " 2.7 Serum folate concentration (nM) Multiple linear regression. Model summary Var Effect P (Intercept) 53.35 (40.73, 69.88) &lt;0.0001 metab.C2MetS 0.98 (0.90, 1.06) 0.58 StudySTOP 1.15 (1.06, 1.25) 0.0008 GA_samp 0.98 (0.96, 0.99) 0.006 metab.C2MetS:StudySTOP 0.93 (0.82, 1.06) 0.30 Estimated marginal means metab.C2 Study response SE df lower.CL upper.CL No MetS SCOPE 38.52 0.99 2242 36.63 40.50 MetS SCOPE 37.65 1.61 2242 34.63 40.94 No MetS STOP 44.43 1.01 2242 42.49 46.45 MetS STOP 40.58 2.09 2242 36.68 44.89 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.98 (0.90, 1.06) 0.6 MetS / No MetS Study: STOP 0.91 (0.83, 1.01) 0.07 STOP / SCOPE MetS (new): No MetS 1.15 (1.06, 1.25) 0.0008 STOP / SCOPE MetS (new): MetS 1.08 (0.94, 1.24) 0.3 "],["folateb12-ratio.html", "2.8 Folate:B12 ratio", " 2.8 Folate:B12 ratio Multiple linear regression. Model summary Var Effect P (Intercept) 161.88 (117.54, 222.95) &lt;0.0001 metab.C2MetS 1.05 (0.95, 1.16) 0.33 StudySTOP 1.09 (0.99, 1.21) 0.08 GA_samp 0.99 (0.97, 1.02) 0.60 metab.C2MetS:StudySTOP 0.97 (0.83, 1.13) 0.67 Estimated marginal means metab.C2 Study response SE df lower.CL upper.CL No MetS SCOPE 150.36 4.56 2242 141.67 159.58 MetS SCOPE 157.79 7.98 2242 142.90 174.24 No MetS STOP 164.36 4.43 2242 155.90 173.28 MetS STOP 166.89 10.19 2242 148.06 188.11 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 1.05 (0.95, 1.16) 0.3 MetS / No MetS Study: STOP 1.02 (0.90, 1.14) 0.8 STOP / SCOPE MetS (new): No MetS 1.09 (0.99, 1.21) 0.08 STOP / SCOPE MetS (new): MetS 1.06 (0.90, 1.25) 0.5 "],["crp-mgl.html", "2.9 CRP (mg/L)", " 2.9 CRP (mg/L) Multiple linear regression. Model summary Var Effect P (Intercept) 3.08 (1.72, 5.52) 0.0002 metab.C2MetS 1.47 (1.23, 1.76) &lt;0.0001 StudySTOP 0.68 (0.57, 0.82) &lt;0.0001 GA_samp 1.02 (0.98, 1.06) 0.25 metab.C2MetS:StudySTOP 1.46 (1.10, 1.93) 0.008 Estimated marginal means metab.C2 Study response SE df lower.CL upper.CL No MetS SCOPE 4.12 0.23 2192 3.68 4.60 MetS SCOPE 6.04 0.57 2192 5.03 7.26 No MetS STOP 2.81 0.14 2192 2.56 3.09 MetS STOP 6.03 0.67 2192 4.85 7.49 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 1.47 (1.23, 1.76) &lt;0.0001 MetS / No MetS Study: STOP 2.14 (1.73, 2.66) &lt;0.0001 STOP / SCOPE MetS (new): No MetS 0.68 (0.57, 0.82) &lt;0.0001 STOP / SCOPE MetS (new): MetS 1.00 (0.73, 1.35) 1.0 "],["maternal-bmi.html", "2.10 Maternal BMI", " 2.10 Maternal BMI Multiple linear regression. Model summary Var Effect P (Intercept) 26.67 (23.73, 29.98) &lt;0.0001 metab.C2MetS 1.18 (1.14, 1.22) &lt;0.0001 StudySTOP 1.02 (0.99, 1.06) 0.21 GA_samp 1.00 (0.99, 1.00) 0.48 metab.C2MetS:StudySTOP 1.11 (1.05, 1.17) 0.0003 Estimated marginal means metab.C2 Study response SE df lower.CL upper.CL No MetS SCOPE 25.72 0.27 2355 25.19 26.27 MetS SCOPE 30.46 0.54 2355 29.42 31.53 No MetS STOP 26.32 0.27 2355 25.81 26.85 MetS STOP 34.51 0.77 2355 33.03 36.06 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 1.18 (1.14, 1.22) &lt;0.0001 MetS / No MetS Study: STOP 1.31 (1.26, 1.37) &lt;0.0001 STOP / SCOPE MetS (new): No MetS 1.02 (0.99, 1.06) 0.2 STOP / SCOPE MetS (new): MetS 1.13 (1.07, 1.20) &lt;0.0001 "],["red-cell-folate-nmoll.html", "2.11 Red cell folate (nmol/L)", " 2.11 Red cell folate (nmol/L) Multiple linear regression. RCF data available in STOP only. Model summary Var Effect P (Intercept) 1127.30 (1005.14, 1264.30) &lt;0.0001 metab.C2MetS 1.02 (0.97, 1.08) 0.46 GA_samp 1.02 (1.01, 1.03) 0.0003 Estimated marginal means metab.C2 response SE df lower.CL upper.CL No MetS 1394.11 11.44 1160 1371.83 1416.74 MetS 1422.54 36.69 1160 1352.34 1496.38 Post-hoc comparisons Contrast Ratio of Geometric means (95% CI) P-value MetS / No MetS 1.02 (0.97, 1.08) 0.5 "],["404.html", "Page not found", " Page not found The page you requested cannot be found (perhaps it was moved or renamed). You may want to try searching to find the page's new location, or use the table of contents to find the page you are looking for. "]]
